The societal benefits of reducing six behavioural risk factors: an economic modelling study from Australia
Open Access
- 21 June 2011
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 483
- https://doi.org/10.1186/1471-2458-11-483
Abstract
A large proportion of disease burden is attributed to behavioural risk factors. However, funding for public health programs in Australia remains limited. Government and non-government organisations are interested in the productivity effects on society from reducing chronic diseases. We aimed to estimate the potential health status and economic benefits to society following a feasible reduction in the prevalence of six behavioural risk factors: tobacco smoking; inadequate fruit and vegetable consumption; high risk alcohol consumption; high body mass index; physical inactivity; and intimate partner violence.This publication has 16 references indexed in Scilit:
- Rapid mortality falls after risk-factor changes in populationsThe Lancet, 2011
- Economic Benefits of Achieving Realistic Smoking Cessation Targets in AustraliaAmerican Journal of Public Health, 2011
- Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for AustraliaStroke, 2009
- Priority setting in health: origins, description and application of the Australian Assessing Cost–Effectiveness initiativeExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco usePublished by Elsevier ,2007
- Time use, work and overlapping activities: evidence from AustraliaCambridge Journal of Economics, 2003
- The Relationship between Modifiable Health Risks and Group-Level Health Care ExpendituresAmerican Journal of Health Promotion, 2000
- Possibilities for Including the Opportunity Cost of Time in Recreation Demand SystemsLand Economics, 1999
- A Practical Guide for Calculating Indirect Costs of DiseasePharmacoEconomics, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995